Patent details

Basic Information

Publication number:

EP3125935

PCT Application Number:

EP2015000525

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157107145

PCT Publication Number:

WO2015149909

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATIONS OF CANCER THERAPEUTICS

French Title of Invention:

ASSOCIATIONS DE TRAITEMENTS ANTINÉOPLASIQUES

German Title of Invention:

KOMBINATIONEN AUS THERAPEUTIKA FÜR KREBS

SPC Number:

Dates

Filing date:

09/03/2015

Grant date:

23/10/2019

EP Publication Date:

08/02/2017

PCT Publication Date:

08/10/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/10/2019

EP B1 Publication Date:

23/10/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/03/2020

Expiration date:

09/03/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/10/2019

 

 

Name:

Merck Patent GmbH

Address:

Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)

Inventor

1

Name:

KALETA, Remigiusz

Address:

United States (US)

2

Name:

MACHL, Andreas

Address:

United States (US)

3

Name:

WILKER, Erik

Address:

United States (US)

4

Name:

HUCK, Bayard R.

Address:

Germany (DE)

Priority

Priority Number:

201461974765 P

Priority Date:

03/04/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/517; A61K 39/395; A61K 45/06; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201943

Publication date:

23/10/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages